TPG Capital Asia snaps up Gribbles Pathology as part of US$200m acquisition

It has 37 facilities across Malaysia.

Private equity firm TPG Capital Asia has completed the acquisition of Gribbles Pathology, a leading diagnostic services provider in Malaysia.

The acquisition is part of the firm's A$279 million (US$200m) purchase of Healthscope Ltd's Asian pathology laboratories in Malaysia, Singapore, and Vietnam.

Gribbles Pathology Malaysia is the largest private provider of diagnostic laboratory services in the region. Head-quartered in Petaling Jaya, it employs over 500 staff and has a network of 37 electronically linked pathology facilities throughout Peninsular Malaysia, Sabah and Sarawak. It currently performs tests for over 1.5 million patients per year.

"We hope to be able to continue to grow our presence in Malaysia and at the same time be a leader in the application of new technology and quality of service to the doctors and healthcare professionals that depend on us," said Tan Sri Dr Yahya Awang, Gribbles' incoming chairman.